详情页 - 首都医科大学宣武医院知识库

当前位置：首页 > 详情页

The effects of erythropoietin on neurogenesis after ischemic stroke

76| 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Institute of Cerebrovascular Disease Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, 100053, P. R. China [2]Beijing Geriatric Medical Research Center and Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, 100053, P. R. China [3]Beijing Institute for Brain Disorders, Beijing, 100053, P. R. China

出处：

DOI：

ISSN：

关键词： Erythropoietin neurogenesis ischemic stroke clinical translation neurology

摘要：

Erythropoietin has been researched for its neuroprotective effects in ischemic stroke for over 30 years. Although erythropoietin can cause side effects that need to be controlled, it has been suggested to be effective in enhancing the prognosis of patients who are out of the therapeutic time window and have not received recombinant tissue plasminogen activator therapy. Studies on the mechanism of the function of erythropoietin have shown that it has various protective effects in ischemic brain injury after stroke, including promoting neurogenesis. In this review, we discuss the effects of erythropoietin on neurogenesis after ischemic brain injury and provide references for effective treatments for ischemic stroke, which is one of the leading causes of death worldwide.

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2019]版：

大类 | 4 区医学

小类 | 4 区神经科学

最新[2023]版：

大类 | 4 区医学

小类 | 4 区神经科学

JCR分区：

出版当年[2018]版：

Q4 NEUROSCIENCES

最新[2023]版：

Q3 NEUROSCIENCES

影响因子： 2.5 最新[2023版] 2.2 最新五年平均 1.139 出版当年[2018版] 0.983 出版当年五年平均 0.662 出版前一年[2017版] 1.193 出版后一年[2019版]

第一作者：

第一作者机构： [1]Institute of Cerebrovascular Disease Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, 100053, P. R. China [2]Beijing Geriatric Medical Research Center and Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, 100053, P. R. China

通讯作者：

通讯机构： [1]Institute of Cerebrovascular Disease Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, 100053, P. R. China [2]Beijing Geriatric Medical Research Center and Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, 100053, P. R. China [3]Beijing Institute for Brain Disorders, Beijing, 100053, P. R. China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Recombinant human erythropoietin increases cerebral cortical width index and neurogenesis following ischemic stroke [2]缺血性卒中药物临床前研究的挑战及其对策 [3]Angiopoietin-like 4 promotes angiogenesis and neurogenesis in a mouse model of acute ischemic stroke [4]变构促红细胞生成素对小鼠脑缺血后神经新生和血管新生的影响 [5]MEPO promotes neurogenesis and angiogenesis but suppresses gliogenesis in mice with acute ischemic stroke [6]Long Noncoding RNA H19 Prevents Neurogenesis in Ischemic Stroke through p53/Notch1 pathway. [7]Herbal Formula Danggui-Shaoyao-San Promotes Neurogenesis and Angiogenesis in Rat Following Middle Cerebral Artery Occlusion [8]Asymmetric Dimethylarginine in Response to Recombinant Tissue-Type Plasminogen Activator and Erythropoietin in Acute Stroke [9]Enhanced Neurogenesis and Collaterogenesis by Sodium Danshensu Treatment After Focal Cerebral Ischemia in Mice [10]Is the beta Common Receptor the Key Molecule for the Protective Effect of Erythropoietin?